Betimol

Betimol is a brand name of timolol ophthalmic, approved by the FDA in the following formulation(s):

BETIMOL (timolol - solution/drops; ophthalmic)

• 
  Manufacturer: SANTEN OY
  
  Approval date: March 31, 1995
  
  Strength(s): EQ 0.25% BASE ^[RLD], EQ 0.5% BASE ^[RLD]

Has a generic version of Betimol been approved?

No. There is currently no therapeutically equivalent version of Betimol available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Betimol. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Betimol.

See also...

• Betimol Drops Consumer Information (Wolters Kluwer)
• Betimol Consumer Information (Cerner Multum)
• Betimol Advanced Consumer Information (Micromedex)
• Timolol Drops Consumer Information (Wolters Kluwer)
• Timolol Gel Eye Drops Consumer Information (Wolters Kluwer)
• Timolol ophthalmic Consumer Information (Cerner Multum)
• Timolol Ophthalmic Advanced Consumer Information (Micromedex)
• Timolol eent AHFS DI Monographs (ASHP)